Ponni Subbiah, MD, MPH


Rett Syndrome Symptoms and Quality of Life Improvements Through Trofinetide: Ponni Subbiah, MD, MPH

The chief medical officer of Acadia Pharmaceuticals provided commentary on a caregiver analysis assessing beneficial experiences with trofinetide in patients with Rett syndrome. [WATCH TIME: 4 minutes]

Larissa Jank, MD


Impact of Indole 3-Lactate Supplementation in Multiple Sclerosis Animal Models: Larissa Jank, MD

The postdoctoral researcher in the department of neurology at Johns Hopkins School of Medicine discussed findings from a study on the impact of indole 3-lactate supplementation in animal models of multiple sclerosis. [WATCH TIME: 4 minutes]

Erinn E. Beagin, MD


Managing Insomnia: Practical Advice for Community Physicians

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.

Timothy Miller, MD, PhD


Future Thoughts and Reason for Excitement in ALS: Timothy Miller, MD, PhD

The codirector of the ALS Center at Washington University School of Medicine detailed the reasons for hope within the ALS space and the promising innovations in the coming future. [WATCH TIME: 4 minutes]

Donald S. Higgins, Jr., MD


AUPN Leadership Minute Episode 39: Supporting K Awardees

Episode 39 of the AUPN Leadership Minute features Donald S. Higgins Jr, MD, of Veterans Health Administration, Albany Medical College; and Alexandra Nelson, MD, PhD, of the University of California San Francisco. [WATCH TIME: 5 minutes]

Vamshi K. Rao, MD


Advancing Care With Exon Skipping Therapies for Duchenne Muscular Dystrophy: Vamshi Rao, MD

The associate professor of pediatrics in neurology and epilepsy at Northwestern University Feinberg School of Medicine discussed the FDA-cleared phase 1/2 trial of an exon 50 skipping therapy to address the specific mutations causing Duchenne muscular dystrophy. [WATCH TIME: 6 minutes]

Lawrence Newman, MD


Connections Between Migraine and Mental Health: Lawrence Newman, MD

The chair of the American Migraine Foundation spoke about the insight gleaned from a recent survey the foundation conducted assessing links between mental health and migraine care. [WATCH TIME: 4 minutes]

Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath


BTKi Treatment Paradigm

Neurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.

Xiang Qi, PhD


ChatGPT: A Promising Tool to Combat Social Isolation and Loneliness in Older Adults With Mild Cognitive Impairment

Recent advances in artificial intelligence—particularly conversational AI tools such as ChatGPT—suggest promising potential in addressing the issues of loneliness and social isolation in these patient populations.

Patrick Vermersch, MD, PhD


BTKi Treatment Paradigm

Neurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.

Ali Ezzati, MD


Identifying Effective Big Data Techniques to Address Heterogeneity in Migraine: Ali Ezzati, MD

The director of the Neuroinformatics Program at the University of California, Irvine, discussed complexities with different machine learning algorithms in migraine research, including findings from the AMPP study. [WATCH TIME: 5 minutes]

Evanthia Bernitsas, MD


Understanding Disadvantages to African Americans in NMOSD Trials: Evanthia Bernitsas, MD

The neurologist at Wayne State University provided background on why there needs to be a continued focus on including and studying African American patients with NMOSD in trials. [WATCH TIME 3 minutes]

Marcello Paglione, PhD


Givinostat's Multifactorial Mechanism of Action in Duchenne Muscular Dystrophy: Marcello Paglione, PhD

The executive medical lead at Italfarmaco SpA expressed his confidence in givinostat to mitigate the progression of Duchenne muscular dystrophy, emphasizing its multifactorial mechanism of action. [WATCH TIME: 5 minutes]

Elizabeth Cassidy, MPH


Gaining Greater Insights Into Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders: Elizabeth M. Cassidy, MPH

The research project manager at the TSC Alliance provided additional clarity into a new study presented at AES 2023 assessing the links between TSC-associated neuropsychiatric disorders and seizure duration. [WATCH TIME: 4 minutes]

Taylor Gonyou, DO


Gauging MS Disease Activity Through Octave’s MSDA Test: Taylor Gonyou, DO

The multiple sclerosis fellow at Michigan Institute for Neurologic Disorders provided perspective on the clinical utility and advantages of a multi-protein test that assesses multiple sclerosis disease activity. [WATCH TIME: 3 minutes]

Rachel Horne


Medical Gaslighting: Multiple Sclerosis’ Dirty Little Secret?

The effect of gaslighting on patients can result in serious harms, and although it is potentially common in the MS care continuum, whether it is deliberate or an institutional problem, it must be called out by providers.

Rachel Brandstadter, MD


Pregnancy and Family Planning Considerations When Treating Patients With Multiple Sclerosis

In this episode of MEDcast, Dr Krieger, Dr Brandstadter, and Dr Bove discuss MS care in patients who are considering pregnancy. They highlight treatment options, monitoring recommendations during and after pregnancy, as well as other crucial considerations when caring for patients with childbearing goals.

Prashanth Rajarajan, MD, PhD


Safety of Cancer Treatments in Patients With Multiple Sclerosis: Prashanth Rajarajan, MD, PhD

The neurology resident at Massachusetts General Brigham talked about assessing the safety of cancer treatments in patients with multiple sclerosis using checkpoint inhibitors. [WATCH TIME: 6 minutes]

Robert K. Shin, MD


The State of Multiple Sclerosis Therapy and Trends in Thinking: Robert K. Shin, MD

The professor of neurology at MedStar Georgetown University Hospital shared his perspective on the trends in thinking about the treatment of MS and how an improved understanding of underlying processes has led to a shift in the field. [WATCH TIME: 5 minutes]

Robert Griggs, MD


Ethical Values and Principals in Neurology Departments, Medical School

A group of esteemed panelists discussed the important values neurology department directors and educators should prioritize when teaching students of the future. [WATCH TIME: 6 minutes]

Jude Luker, BA (Hons)


The Urgent Need for Improved Physician-Patient Conversations on SUDEP: Jude Luker, BA (Hons)

The head of Patient Engagement, Epilepsy and Rare Syndromes (Europe) at UCB Pharma discussed the inconsistencies in educational information given to patients with epilepsy, including the knowns of sudden unexpected death. [WATCH TIME: 4 minutes]

John Morren, MD


Building the Myasthenia Gravis Armamentarium

Since it was first discovered in the early 1900s, the therapeutic approaches to treating myasthenia gravis have changed significantly, with several proven treatment options.

Dawn Edhe, PhD


State of Mental Health Care for Patients With MS: Dawn Edhe, PhD

The psychologist and professor in the department of rehabilitation medicine at the University of Washington shared her perspective on the state of mental health care in multiple sclerosis. [WATCH TIME: 4 minutes]

Karin Cook


Questions of Adherence Raised by Unused Multiple Sclerosis Disease-Modifying Therapies: Darin T. Okuda, MD; Karin Cook

The coauthors of a study assessing costs associated with unused disease-modifying therapies shared their insight into the extended effects of unused treatments in MS, including the importance of transparency between physician and patient. [WATCH TIME: 12 minutes]

Renee Shellhaas, MD, MS, FAES


Need for Increased Multidisciplinary Study of Newborn and Infant Sleep in Epilepsy: Renee Shellhaas, MD, MS, FAES

The professor of neurology at Washington University School of Medicine in St. Louis spoke about the field of newborn sleep and epilepsy based on a special lecture from the 2022 AES annual meeting. [WATCH TIME: 3 minutes]

Tudor Jovin, MD


Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

The medical director of the Cooper Neurological Institute and the professor of neurology at Yale University School of Medicine shared a few highlights from research presented at ISC 2024. [WATCH TIME: 7 minutes]

Thomas Wisniewski, MD


Exponential Growth of Research, Biomarkers in Alzheimer Disease: Thomas Wisniewski, MD

The director of NYU Langone’s Alzheimer’s Disease Research Center discussed noticeable advancements within the field of Alzheimer disease in recent years and how they contribute to gaining a better understanding of the disease. [WATCH TIME: 5 minutes]

Jonathan R. Isaacson, MD


Read All About It: How On-Demand Therapy Has Changed the PD Landscape

As therapeutic development has advanced in Parkinson disease management, the introduction of on-demand options have extended ON time for patients and altered the paradigm of care.

J. William Lindsey, MD


Exploring Epstein Barr Virus Connection in Multiple Sclerosis Research: J. William Lindsey, MD

The professor in the department of neurology with McGovern Medical School at UTHealth Houston talked about findings from a recent study that investigated T cell specificity in the spinal fluid of patients with multiple sclerosis. [WATCH TIME: 10 minutes]

Ana Krieger, MD, MPH


Prioritizing Sleep Health in the Modern World of Sleep Disorders: Ana Krieger, MD, MPH

The medical director of the Center for Sleep Medicine at Weill Cornell Medicine talked about the importance of sleep health in modern life with the increasing prevalence of sleep disorders such as narcolepsy in the United States. [WATCH TIME: 5 minutes]

© 2024 MJH Life Sciences

All rights reserved.